Published trade mark details for 2639047

This information was published on 2026-04-20T08:05:17 for IP Right Acceptance Published.

Field	Value
(210)	2639047 (IR 1910098)
(220)	04 Feb 2026
(300)	US, 26 Aug 2025, 99358616
(500)	The mark consists of a sequence of right pointing arrows colored pink on the left shading into orange and the word "INGREZZA". The "ING" is colored pink on the left shading into orange and the "REZZA" is colored purple. The white in the mark is background and is not claimed as a feature. The color(s) pink, orange, and purple is/are claimed as a feature of the mark. The mark consists of a sequence of right pointing arrows colored pink on the left shading into orange and the word "INGREZZA". The "ING" is colored pink on the left shading into orange and the "REZZA" is colored purple. The white in the mark is background and is not claimed as a feature.
(511) (510)	Class 5 Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of tardive dyskinesia; pharmaceutical preparations for the treatment of Huntington's Disease and chorea associated with Huntington's Disease. Class 44 Providing medical information; providing medical information in the field of neurological, central nervous system, psychiatric and movement diseases, disorders, and conditions; providing medical information in the field of tardive dyskinesia; providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease.
(540)
(550)	Figurative
(730)	Neurocrine Biosciences, Inc.
(750)	Mallesons

 

Find out more about publications on the About page.